|
|
J Shellito, V V Suzara, W Blumenfeld, J M Beck, H J Steger, T H Ermak
J Clin Invest. 1990;
85(5):1686
doi:10.1172/JCI114621
Abstract |
Full text
| PDF

P
ulmonary infections with Pneumocystis carinii are an important cause of morbidity and mortality in patients with AIDS. P. carinii infections are seen in patients with decreased numbers of helper T lymphocytes, suggesting that these cells are important in preventing infection. To test this hypothesis, we sought to establish experimental infection with P. carinii in mice selectively depleted of helper T lymphocytes. Weekly injections of a monoclonal anti-CD4 antibody produced sustained depletion of helper T lymphocytes from blood and lymphoid organs. To establish pulmonary infection, lymphocyte-depleted mice were then given intratracheal inoculations of P. carinii organisms derived from the lungs of chronically infected athymic mice. Pulmonary infection with P. carinii was demonstrable in the antibody-treated mice and was centered around the conducting airways. Infection was persistent for up to 3 mo with continued antibody treatments, and yet could be cleared from the lungs if antibody treatments were discontinued. This experimental model of P. carinii infection permits the study of infection associated with a specific immune defect and implicates the helper T lymphocyte as a critical cell in host defense against this pathogen.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(33)
| Title and authors |
Publication |
Year |
CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals
Matthew W. Auten, Weitao Huang, Guixiang Dai, Alistair J. Ramsay
|
Vaccine
|
2012 |
Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation
G. H. Struijk, A. F. Gijsen, S. L. Yong, A. H. Zwinderman, S. E. Geerlings, K. D. Lettinga, K. A. M. I. van Donselaar-van der Pant, I. J. M. ten Berge, F. J. Bemelman
|
Nephrology Dialysis Transplantation
|
2011 |
Cytokines and the regulation of fungus-specific CD4 T cell differentiation
Vanessa Espinosa, Amariliz Rivera
|
Cytokine
|
2011 |
Topley & Wilson's Microbiology and Microbial Infections
Melanie T. Cushion
|
Topley & Wilson's Microbiology and Microbial Infections
|
2010 |
Chronic hepatitis C with autoimmune phenomenon complicated with Pneumocystis pneumonia: A rare case that developed following steroid treatment and finally responded to PEG-IFNα-2b plus ribavirin combination therapy
Yohei Waseda, Katsura Hirano, Satoko Inagaki, Yoshinori Goto, Shinya Yamada, Kazuhiro Miwa, Yoshibumi Kaneko, Hisashi Doyama
|
Kanzo
|
2010 |
Current understanding ofPneumocystisimmunology
Michelle N Kelly, Judd E Shellito
|
Future Microbiology
|
2010 |
Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina
R. R. Rapaka, D. M. Ricks, J. F. Alcorn, K. Chen, S. A. Khader, M. Zheng, S. Plevy, E. Bengten, J. K. Kolls
|
Journal of Experimental Medicine
|
2010 |
Pneumocystis pneumonia in children
Vasilios Pyrgos, Shmuel Shoham, Emmanuel Roilides, Thomas J. Walsh
|
Paediatric Respiratory Reviews
|
2009 |
Variation in the Major Surface Glycoprotein Genes inPneumocystis jirovecii
Geetha Kutty, Frank Maldarelli, Guillaume Achaz, Joseph A. Kovacs
|
J INFECT DIS
|
2008 |
Current insights into the biology and pathogenesis of Pneumocystis pneumonia
Charles F. Thomas, Andrew H. Limper
|
Nat Rev Micro
|
2007 |
|